DEE FANNING: Open Payments
NPI 1205435112 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 83 payments from 14 companies in 2025. Trend: 2023 $743 · 2024 $1,107 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $351 |
| ABBVIE INC. | 20 | $307 |
| Janssen Biotech, Inc. | 12 | $178 |
| Madrigal Pharmaceuticals | 5 | $126 |
| QOL Medical, LLC | 4 | $120 |
| Ipsen Biopharmaceuticals, Inc | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 10 | $78 |
| PFIZER INC. | 3 | $52 |
| Celltrion USA Inc. | 2 | $41 |
Products named: ENTYVIO, TREMFYA, RINVOQ, REZDIFFRA, Sucraid, IQIRVO, DUPIXENT, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
